Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regenerx Biopharmaceuticals Inc (RGN)  
$0.01 0.00 (0.00%) as of 4:30 Tue 10/17


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 106,883,000
Market Cap: 1.04(M)
Last Volume: 9,926 Avg Vol: 77,919
52 Week Range: $0.009725 - $0.047
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tss4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tss4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 140
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2006-03-06 4 B $2.81 $2,056,499 I/I 731,850 10,914,694 1.5     -
   Goldstein Allan L Director   –       •      –    2006-01-06 4 GD $0.00 $0 D/D 2,500 1,952,536     -
   Goldstein Allan L Director   –       •      –    2005-12-21 4 GD $0.00 $0 D/D 2,500 1,955,036     -
   Cavazza Paolo 10% Owner   –       –       •   2005-08-01 4 B $0.00 $352,000 I/I 110,000 984,615 1.5     -
   Goldstein Allan L Director   –       •      –    2005-08-01 4 S $3.20 $352,000 D/D (110,000) 1,965,536     -
   Cavazza Claudio 10% Owner   –       –       •   2005-06-22 4 B $3.25 $1,999,998 I/I 615,384 307,692 1.5     -
   Cavazza Paolo 10% Owner   –       –       •   2005-06-22 4 B $3.25 $3,999,999 I/I 1,230,769 923,077 1.5     -
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2005-06-22 4 B $0.00 $0 D/D 0 984,615 2.37     -
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2005-06-22 4 B $3.25 $999,999 I/I 307,692 10,182,844 1.5     -
   Goldstein Allan L Director   –       •      –    2005-06-20 4 GD $0.00 $0 D/D 8,000 1,957,536     -
   Mcnay Joseph C Director   –       •      –    2005-05-01 4 OE $0.53 $2,650 D/D 5,000 1,147,795     -
   Finkelstein J J President and CEO   •       •      –    2005-04-22 4 GA $0.00 $0 I/I 6,000 28,500     -
   Finkelstein J J President and CEO   •       •      –    2005-04-22 4 GD $0.00 $0 D/D 18,000 1,553,138     -
   Sigma Tau Finanziaria Spa 10% Owner   –       –       •   2005-01-07 4/A B $0.00 $0 I/I 0 9,875,152 1.42     -
   Sigma Tau Finanziaria Spa 10% Owner   –       –       •   2005-01-07 4/A B $0.00 $0 D/D 0 9,875,152 2.37     -
   Cavazza Claudio 10% Owner   –       –       •   2005-01-07 4 B $3.25 $3,199,999 I/I 984,615 984,615 1.5     -
   Cavazza Paolo 10% Owner   –       –       •   2005-01-07 4 B $3.25 $3,199,999 I/I 984,615 984,615 1.5     -
   Sigma Tau Finanziaria Spa 10% Owner   –       –       •   2005-01-03 4 B $3.25 $3,199,999 D/D 984,615 10,859,766 2.45     -
   Goldstein Allan L Director   –       •      –    2004-09-10 4 GD $0.00 $0 D/D 10,000 1,979,320     -
   Cavazza Claudio 10% Owner   –       –       •   2004-09-03 4 OE $1.09 $1,499,999 I/I 1,382,488 9,875,152     -
   Cavazza Paolo 10% Owner   –       –       •   2004-09-03 4 OE $1.09 $1,499,999 I/I 1,382,488 9,875,152     -
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2004-09-03 4 OE $1.09 $1,499,999 I/I 1,382,488 9,875,151     -
   Finkelstein J J President and CEO   •       •      –    2004-07-21 4 GD $0.00 $0 D/D 25,000 1,571,138     -
   Cavazza Claudio 10% Owner   –       –       •   2004-01-23 4 B $0.95 $1,000,000 I/I 1,052,632 8,492,664 1.5     -
   Cavazza Paolo 10% Owner   –       –       •   2004-01-23 4 B $0.95 $1,000,000 I/I 1,052,632 8,492,664 1.5     -
  140 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us